ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 78 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $268,000 | +30.7% | 3,230 | +21.1% | 0.00% | 0.0% |
| Q4 2020 | $205,000 | +425.6% | 2,668 | -74.8% | 0.00% | – |
| Q4 2017 | $39,000 | -15.2% | 10,600 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $46,000 | +170.6% | 10,600 | 0.0% | 0.00% | – |
| Q2 2017 | $17,000 | -15.0% | 10,600 | 0.0% | 0.00% | – |
| Q1 2017 | $20,000 | -83.6% | 10,600 | -36.1% | 0.00% | -100.0% |
| Q3 2016 | $122,000 | +60.5% | 16,587 | +16.5% | 0.00% | 0.0% |
| Q2 2016 | $76,000 | – | 14,237 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |